ECONOMIC ANALYSIS OF EVARREST SEALANT MATRIX COMPARED WITH STANDARD OF CARE IN SEVERE SOFT TISSUE SURGICAL BLEEDING- A FRANCE HOSPITAL PERSPECTIVE
Author(s)
Jamous N1, Thanh TN2, Ferko N3, Hogan A3, Batiller J4, Kocharian R5, Danker III W6
1Ethicon Biosurgery, Berkshire, UK, 2Johnson & Johnson, Issy-les-Moulineaux, France, 3Cornerstone Research Group Inc., Burlington, ON, Canada, 4Ethicon Biosurgery, USA, Somerville, NJ, USA, 5Ethicon, Inc., Somerville, NJ, USA, 6Global Health Economics and Market Access, Ethicon, Inc., Somerville, NJ, USA
OBJECTIVES:
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PMD16
Topic
Economic Evaluation
Topic Subcategory
Budget Impact Analysis
Disease
Systemic Disorders/Conditions